Court Reaffirms Right of Myriad Genetics to Patent Genes

August 20, 2012

A federal appeals court reaffirmed on Thursday the right of Myriad Genetics to patent two genes linked to breast and ovarian cancer, after the Supreme Court told it to take another look at the hotly contested case. (NY Times)